Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Geron Corp GERN

Alternate Symbol(s):  GERNW

Healthcare Biotechnology
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the... see more

Recent & Breaking News (NDAQ:GERN)

MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Geron Corporation and Encourages Investors with Losses to Contact the Firm

Business Wire March 23, 2020

GERN FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm

ACCESSWIRE IA March 23, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application Deadline Today, Investors with Losses Should Contact Firm Immediately

ACCESSWIRE IA March 23, 2020

FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 23, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application Deadline Tomorrow, Investors with Losses Encouraged to Contact Firm

ACCESSWIRE IA March 22, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GERN, CCI and TLRY

ACCESSWIRE IA March 22, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 2 Days to Application Deadline, Investors with Losses Encouraged to Contact Firm

ACCESSWIRE IA March 21, 2020

FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 21, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application Deadline 3 Days Away, Investors with Losses Encouraged to Contact Firm

GlobeNewswire March 20, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, ALGN and CRON

ACCESSWIRE IA March 20, 2020

3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 20, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GERN, WWE and CRON

ACCESSWIRE IA March 20, 2020

GERN UPCOMING DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm

ACCESSWIRE IA March 20, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 4 Days Until Application Deadline, Investors with Losses Encouraged to Contact Firm

ACCESSWIRE IA March 19, 2020

CLASS ACTION UPDATE for GERN, AAN and MGPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA March 19, 2020

4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 19, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, JELD and CRON

ACCESSWIRE IA March 19, 2020

GERN FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm

Business Wire March 19, 2020

SHAREHOLDER ALERT: GERN LK BDX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA March 19, 2020

MARCH 23 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 19, 2020